imatinib mesylate has been researched along with Bilharziasis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khalifa, SE | 1 |
1 other study(ies) available for imatinib mesylate and Bilharziasis
| Article | Year |
|---|---|
Immunohistochemical expression of CD117/KIT, HER2, and ErĪ² in schistosomal and non-schistosomal urothelial carcinoma of Egyptian patients.
Topics: Carcinoma, Transitional Cell; Egypt; Estrogen Receptor beta; Humans; Imatinib Mesylate; Schistosomiasis; Urinary Bladder Neoplasms | 2023 |